Introduction
The fetal pituitary-adrenal system starts functioning between days 17 and 18 of pregnancy in rats (Dupouy et al, 1975) , and an important modulating role for corticosterone of maternal ori¬ gin is well established (Yamamoto et al, 1983) . In rats the fetal adrenals hypertrophy between day 18 and day 22 of pregnancy after maternal adrenalectomy on day 14 . This has been inter¬ preted as a compensatory response of the fetal pituitaryadrenal axis to a fall in circulating glucocorticoids derived from an adrenalectomized mother; corticosterone, but not ACTH (which would be increased in mothers after adrenalectomy), crosses the placenta from the maternal to the fetal circulation (Zarrow et al, 1970; Wong and Burton, 1974; Dupouy et al, 1980) . The presence of glucocorticoid receptors in the placenta has been reported in rats (Heller et al, 1981 ) and mice (Wong and Burton, 1974) . Glucocorticoids may play a role in the inhibition of placental progesterone secretion during midpregnancy (Heller and DeNicola, 1983) . Most progesterone in the maternal circulation is secreted by the maternal ovaries (Pointis et al, 1981) . The decrease in placental progesterone secretion that occurs at mid-pregnancy is associated with an induction of corticosterone metabolism by the placenta (Pepe and Albrecht, 1984) , and, thus, a decrease in the passage of corticosterone from the maternal to the fetal circulation. In mice, Correspondence.
Revised manuscript received 15 June 1992. this occurs on day 11 (Montano et al, 1991) , when there is a dramatic increase in corticosterone in maternal blood following a marked increase in placental androgen secretion on days 9 and 10 of pregnancy (Barkley et at., 1979; Soares and Talamantes, 1982, 1983; F. S. vom Saal, unpublished) . Androgens syn¬ thesized by the placenta are secreted into maternal and fetal compartments and are substrates for oestrogen biosynthesis in the maternal ovary (Jackson and Albrecht, 1985; Gibori et al, 1988) and possibly also in fetuses (vom Saal et al, 1992) . The dramatic changes in maternal glucocorticoid concentrations beginning during mid-pregnancy could influence steroid hor¬ mone (androgen, oestrogen, glucocorticoid) concentrations in the fetal circulation. In addition, it is possible that sex differ¬ ences in placental binding or metabolism of corticosteroids could be due to serum differences in these steroids between male and female fetuses (Ward and Weisz, 1980; Wilke et al, 1982; vom Saal et al, 1990; Montano et al, 1991) .
Changes in maternal glucocorticoid concentrations owing to maternal stress or maternal adrenalectomy also influence andro¬ gen and glucocorticoid concentrations in the fetal circulation (Ward and Weisz, 1980; vom Saal et al, 1990; Montano et al, 1991 adrenalectomized stress, = 8. 'Significant difference between male and female fetuses (P < 0.01).
after the last stress session (Fig. 2) , which was consistent with previous findings (Montano et al, 1991) .
In fetuses from intact, control mothers, females had signifi¬ cantly (58%) higher concentrations of corticosterone in plasma than did males (P < 0.01; Fig. 3 ). However, no sex difference in fetal adrenal corticosterone content was observed in these fetuses (Fig. 4) (Fig. 3) . In both male and female fetuses from intact mothers, only a slight but nonsignifi¬ cant decrease in adrenal corticosterone content was observed as a result of maternal stress (Fig. 4) (Dupouy et al, 1975) or days 19 and 20 . Day 17-18 of pregnancy in rats roughly corresponds to days [16] [17] of pregnancy in mice (Schlegel et ai, 1967; Rugh, 1969 
